Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

被引:7
|
作者
Gao, Feng [1 ]
Chen, Gang [2 ,3 ,4 ]
Byrne, Christopher D. [5 ,6 ]
Targher, Giovanni [7 ,8 ]
Cheung, Tan To [9 ]
Zheng, Ming-Hua [10 ,11 ,12 ,13 ]
机构
[1] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Affiliated Hosp 1, Wenzhou, Peoples R China
[5] Univ Hosp Southampton, Southampton Natl Inst Hlth & Care Res, Biomed Res Ctr, Southampton, England
[6] Univ Southampton, Southampton Gen Hosp, Southampton, England
[7] Univ Verona, Dept Med, Verona, Italy
[8] IRCCS Sacro Cuore Don Calabria Hosp, I-37024 Negrar Di Valpolicella, Italy
[9] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
[10] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[13] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
基金
中国国家自然科学基金;
关键词
Metabolic dysfunction-associated fatty liver disease (MAFLD); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease; hepatocellular carcinoma (HCC); epidemiology;
D O I
10.21037/hbsn-23-539
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:945 / 948
页数:4
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    [J]. JHEP REPORTS, 2023, 5 (09)
  • [2] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    [J]. JAMA NETWORK OPEN, 2024, 7 (07)
  • [3] Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease
    Yeoh, Aaron
    Yang, Zeyuan
    Cheung, Ramsey
    Do, Albert
    Ahmed, Aijaz
    Wong, Robert J.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (07) : 718 - 725
  • [4] Impact of metabolic dysfunction-associated fatty liver disease on the outcomes following laparoscopic hepatectomy for hepatocellular carcinoma
    Xu, Hongwei
    Liu, Yani
    Wei, Yonggang
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024,
  • [6] Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma
    Esteban, Jesus Rivera-
    Munoz-Martinez, Sergio
    Higuera, Monica
    Sena, Elena
    Bermudez-Ramos, Maria
    Banares, Juan
    Martinez-Gomez, Maria
    Cusido, M. Serra
    Jimenez-Masip, Alba
    Francque, Sven M.
    Tacke, Frank
    Minguez, Beatriz
    Pericas, Juan M.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (09)
  • [7] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [8] Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Kim, Aryoung
    Choi, Sung Chul
    Goh, Myungji
    Kang, Wonseok
    Gwak, Geum-Yon
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S631 - S631
  • [9] The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection
    Xiong, Ke-Gong
    Ke, Kun-Yu
    Chen, Li-Fang
    Kong, Jin-Feng
    Lin, Tai-Shun
    Lin, Qing-Biao
    Lin, Su
    Zhu, Yue-Yong
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (04) : 366 - 372
  • [10] A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
    Jeong, Byung-Kwan
    Choi, Won-Il
    Choi, Wonsuk
    Moon, Jieun
    Lee, Won Hee
    Choi, Chan
    Choi, In Young
    Lee, Sang-Hyun
    Kim, Jung Kuk
    Ju, Young Seok
    Kim, Pilhan
    Moon, Young-Ah
    Park, Jun Yong
    Kim, Hail
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)